Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada.
Patient Partner, Canadian Organization for Rare Disorders, Ottawa, ON, Canada.
Trials. 2024 Jan 30;25(1):96. doi: 10.1186/s13063-024-07948-7.
Despite the critical importance of clinical trials to provide evidence about the effects of intervention for children and youth, a paucity of published high-quality pediatric clinical trials persists. Sub-optimal reporting of key trial elements necessary to critically appraise and synthesize findings is prevalent. To harmonize and provide guidance for reporting in pediatric controlled clinical trial protocols and reports, reporting guideline extensions to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) guidelines specific to pediatrics are being developed: SPIRIT-Children (SPIRIT-C) and CONSORT-Children (CONSORT-C).
The development of SPIRIT-C/CONSORT-C will be informed by the Enhancing the Quality and Transparency of Health Research Quality (EQUATOR) method for reporting guideline development in the following stages: (1) generation of a preliminary list of candidate items, informed by (a) items developed during initial development efforts and child relevant items from recent published SPIRIT and CONSORT extensions; (b) two systematic reviews and environmental scan of the literature; (c) workshops with young people; (2) an international Delphi study, where a wide range of panelists will vote on the inclusion or exclusion of candidate items on a nine-point Likert scale; (3) a consensus meeting to discuss items that have not reached consensus in the Delphi study and to "lock" the checklist items; (4) pilot testing of items and definitions to ensure that they are understandable, useful, and applicable; and (5) a final project meeting to discuss each item in the context of pilot test results. Key partners, including young people (ages 12-24 years) and family caregivers (e.g., parents) with lived experiences with pediatric clinical trials, and individuals with expertise and involvement in pediatric trials will be involved throughout the project. SPIRIT-C/CONSORT-C will be disseminated through publications, academic conferences, and endorsement by pediatric journals and relevant research networks and organizations.
SPIRIT/CONSORT-C may serve as resources to facilitate comprehensive reporting needed to understand pediatric clinical trial protocols and reports, which may improve transparency within pediatric clinical trials and reduce research waste.
The development of these reporting guidelines is registered with the EQUATOR Network: SPIRIT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#35 ) and CONSORT-Children ( https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials/#CHILD ).
尽管临床试验对于提供儿童和青少年干预效果的证据至关重要,但仍缺乏已发表的高质量儿科临床试验。关键试验要素的报告不充分,这些要素对于批判性评估和综合研究结果至关重要。为了协调并提供儿科对照临床试验方案和报告的报告指南,正在制定针对儿科的标准干预试验建议报告项目(SPIRIT)和临床试验报告统一标准(CONSORT)指南的扩展:儿科 SPIRIT(SPIRIT-C)和 CONSORT-儿童(CONSORT-C)。
SPIRIT-C/CONSORT-C 的制定将遵循报告指南制定的增强健康研究质量和透明度(EQUATOR)方法,在以下阶段进行:(1)生成候选项目的初步清单,这些候选项目的依据是:(a)初步开发工作中制定的项目和最近发表的 SPIRIT 和 CONSORT 扩展中的儿童相关项目;(b)两项系统评价和文献环境扫描;(c)与年轻人的研讨会;(2)国际 Delphi 研究,广泛的小组成员将使用九点李克特量表对候选项目的纳入或排除进行投票;(3)共识会议,讨论 Delphi 研究中未达成共识的项目,并“锁定”清单项目;(4)对项目和定义进行试点测试,以确保它们易于理解、有用且适用;(5)最终项目会议,讨论试点测试结果背景下的每个项目。关键合作伙伴,包括有儿科临床试验经验的年轻人(12-24 岁)和家庭照顾者(例如父母)以及儿科试验方面的专家和参与者,将在整个项目中参与其中。SPIRIT-C/CONSORT-C 将通过出版物、学术会议以及儿科期刊和相关研究网络和组织的认可进行传播。
SPIRIT/CONSORT-C 可作为资源,促进理解儿科临床试验方案和报告所需的全面报告,从而提高儿科临床试验的透明度并减少研究浪费。
这些报告指南的制定在 EQUATOR 网络上进行了注册:儿科 SPIRIT(https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#35)和 CONSORT-儿童(https://www.equator-network.org/library/reporting-guidelines-under-development/reporting-guidelines-under-development-for-clinical-trials-protocols/#CHILD)。